CYCC - Cyclacel Pharmaceuticals, Inc.
IEX Last Trade
0.324
0 0%
Share volume: 986
Last Updated: Fri 27 Dec 2024 08:29:45 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$0.32
0.00
0.00%
Summary score
25%
Profitability
25%
Dept financing
4%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-14.87%
Return on assets
-12.75%
Return on sales
0%
Return on invested capital
161.84%
Total debt ratio
20.3%
Debt ratio change over timeo
-0.68%
Current Ratio
6.54%
Quick Ratio
0%
Cash Position Ratio
5.87%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.69%
Return on assets
-14.78%
Return on sales
0%
Return on invested capital
404.58%
Total debt ratio
17.84%
Debt ratio change over timeo
-0.91%
Current Ratio
9.92%
Quick Ratio
0%
Cash Position Ratio
8.45%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-8.34%
Return on assets
-8.47%
Return on sales
0%
Return on invested capital
808.76%
Total debt ratio
8.89%
Debt ratio change over time
-0.98%
Current Ratio
18.47%
Quick Ratio
0%
Cash Position Ratio
16.76%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-123.11%
Return on assets
-118.64%
Return on sales
0%
Return on invested capital
45.94%
Total debt ratio
-68.3%
Debt ratio change over time
-0.68%
Current Ratio
7.24%
Quick Ratio
0%
Cash Position Ratio
5.68%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CYCC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.87% | -3.05% | 11.55% | 6.27% |
| Return on assets | -12.75% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 161.84% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 20.3% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.68% | 6.09% | 6.03% | 1.53% |
| Dept financing | 5% | 50% | 43% | 14% |
| Current Ratio | 9.92% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 8.45% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 19% | 41% | 42% |
| Short-term ratios | CYCC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.69% | -25.62% | 17.94% | 7.14% |
| Return on assets | -14.78% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 404.58% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 58% |
| Total debt ratio | 17.84% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.91% | -23.44% | 9.66% | 0.6% |
| Dept financing | 4% | 25% | 45% | 8% |
| Current Ratio | 9.92% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 8.45% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 27% | 22% | 38% |